Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

P1189: INITIAL SAFETY RUN-IN RESULTS OF THE PHASE III POLARGO TRIAL: POLATUZUMAB VEDOTIN PLUS RITUXIMAB, GEMCITABINE, AND OXALIPLATIN IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA

A. McMillan,C. Haioun,J.-M. Sancho,A. Viardot,A. Rodriguez Izquierdo,E. M. Donato Martin,A. M. García-Sancho, J. Sandoval-Sus,H. Tilly, E. Vandenberghe,J. Hirata, P. Choudhry,Y. M. Chang,L. Musick,M. Matasar

HemaSphere（2022）

Cited 2|Views10
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined